JP5588134B2 - Capsule film - Google Patents

Capsule film Download PDF

Info

Publication number
JP5588134B2
JP5588134B2 JP2009184264A JP2009184264A JP5588134B2 JP 5588134 B2 JP5588134 B2 JP 5588134B2 JP 2009184264 A JP2009184264 A JP 2009184264A JP 2009184264 A JP2009184264 A JP 2009184264A JP 5588134 B2 JP5588134 B2 JP 5588134B2
Authority
JP
Japan
Prior art keywords
capsule
gelatin
film
parts
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009184264A
Other languages
Japanese (ja)
Other versions
JP2011037731A (en
Inventor
有見 寺本
直人 鈴木
彰 永田
剛一 西村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Fuji Capsule Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Fuji Capsule Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd, Fuji Capsule Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Priority to JP2009184264A priority Critical patent/JP5588134B2/en
Publication of JP2011037731A publication Critical patent/JP2011037731A/en
Application granted granted Critical
Publication of JP5588134B2 publication Critical patent/JP5588134B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

本発明は、カプセル皮膜及びそれを用いたカプセル、並びにカプセルの製造方法に関する。   The present invention relates to a capsule film, a capsule using the capsule film, and a capsule manufacturing method.

カプセルは、医薬品、食品、化粧品等の幅広い分野において用いられている。最も汎用されているカプセル基剤はゼラチンであり、ゼラチンカプセルは安価で毒性がなく、優れた機械的強度、崩壊性等を示す。しかし一方で、ゼラチンは、牛、豚、魚等の動物を原料とするため、ゼラチン独特の獣臭がすると云う問題が指摘されていた。   Capsules are used in a wide range of fields such as pharmaceuticals, foods, and cosmetics. The most widely used capsule base is gelatin. Gelatin capsules are inexpensive and non-toxic and exhibit excellent mechanical strength, disintegration, and the like. On the other hand, however, since gelatin is made from animals such as cattle, pigs and fish, there has been a problem that it has a peculiar animal odor.

また、カプセルには、遮光性を付与し、カプセル内容物の光変化(変色・分解等)を抑制する観点及び内容物をマスキングする観点等から、通常、着色剤が配合されている。カプセルを着色することは、識別性を与え摂取時の誤飲を低減する観点からも重要である。カプセルに用いられる着色剤としては、酸化チタン等の顔料、タール色素等の合成色素、カロチノイド系色素、フラボノイド系色素、カラメル色素等の天然色素がある。とりわけ、耐熱性、耐光性等に優れる酸化チタンやカラメル色素が汎用されている。
しかし、現在の日本の国内法令によれば、顔料や合成色素だけでなく、天然色素を使用した場合も製品への添加物の表示が義務づけられている。昨今の消費者の健康志向に伴って、添加物表示のいらない製品への要望が高まっており、着色剤を添加しなくても優れた遮光性を有するカプセル皮膜が求められているのが実状である。
In addition, a colorant is usually blended in the capsule from the viewpoint of imparting light-shielding properties, suppressing light change (discoloration, decomposition, etc.) of the capsule contents, and masking the contents. Coloring the capsule is also important from the viewpoint of providing distinctiveness and reducing accidental ingestion when ingested. Examples of the colorant used in the capsule include pigments such as titanium oxide, synthetic pigments such as tar pigments, and natural pigments such as carotenoid pigments, flavonoid pigments, and caramel pigments. In particular, titanium oxide and caramel color having excellent heat resistance and light resistance are widely used.
However, according to current Japanese laws and regulations, not only pigments and synthetic dyes, but also natural dyes must be labeled with additives. With the recent trend toward consumer health, there is an increasing demand for products that do not require additive labeling, and there is a demand for capsule films that have excellent light-shielding properties even without the addition of colorants. is there.

一方、杜仲は、トチュウ科トチュウ属の一科一属一種に分類される落葉性木本類で、樹高が20mに達する喬木である。杜仲の樹皮や葉は、医薬品、食品素材として広く利用されている。杜仲には種々の効能が知られており、例えば、杜仲葉は、高血圧抑制(非特許文献1)、高脂血症抑制(特許文献1)、血清VLDL減少、脳血管障害発生率低下(非特許文献2)、1型糖尿病(インスリン依存型糖尿病)改善(非特許文献3)等の作用を有することが報告されている。また、杜仲にメルカプタン等に対する消臭作用があることが報告されている(特許文献2)。
しかしながら、杜仲加工物をカプセル皮膜に配合することは何ら報告されていない。
On the other hand, Tochu is a deciduous woody tree that is classified as a genus of a family belonging to the genus Eucommia and is a vine that reaches a height of 20 m. Tochu's bark and leaves are widely used as pharmaceuticals and food ingredients. A variety of effects are known for Tochu, for example, Tochu Naka has been shown to suppress hypertension (Non-patent Document 1), suppress hyperlipidemia (Patent Document 1), decrease serum VLDL, and reduce the incidence of cerebrovascular disorders (Non-patent Document 1). Patent Document 2) has been reported to have effects such as improvement of type 1 diabetes (insulin-dependent diabetes) (Non-patent Document 3). In addition, it has been reported that Tochu has a deodorizing effect on mercaptans and the like (Patent Document 2).
However, there has been no report of blending a processed product into a capsule film.

特許第3435415号公報Japanese Patent No. 3435415 特開2005−289952号公報JP 2005-289952 A

Health Sciences 2005;vol.21,No.2:198−210Health Sciences 2005; vol. 21, no. 2: 198-210 日本栄養・食糧学会要旨集52;1998:260Abstracts of Japanese Society of Nutrition and Food 52; 1998: 260 Diabetes Research and Clinical Practice 2005;67:22−28Diabetes Research and Clinical Practice 2005; 67: 22-28

本発明は、上記の如き従来の問題と実状に鑑みてなされたものであり、ゼラチン独特の獣臭が低減され、遮光性に優れたカプセル皮膜及びこれを用いたカプセルを提供することを課題とする。   The present invention has been made in view of the above-described conventional problems and actual situations, and has an object to provide a capsule film that reduces gelatin-specific animal odor and has excellent light-shielding properties and a capsule using the capsule film. To do.

本発明者は、当該課題を解決すべく種々研究を重ねた結果、ゼラチンを含有するカプセル皮膜に杜仲加工物を共存させれば、ゼラチン独特の獣臭が低減され、さらにカプセル皮膜に遮光性を付与することができ、カプセル内容物のマスキング及び透過光による内容物の光変化(変色・分解等)の抑制に有用であることを見出し、本発明を完成した。   The present inventor has conducted various studies to solve the problem, and as a result, if the processed starch is coexisted with the capsule film containing gelatin, the animal odor peculiar to gelatin is reduced, and the capsule film has light shielding properties. The present invention was completed by finding that it can be applied and useful for masking the capsule contents and suppressing light changes (discoloration, decomposition, etc.) of the contents due to transmitted light.

すなわち、本発明は、ゼラチン及び杜仲加工物を含有することを特徴とするカプセル皮膜により上記課題を解決したものである。
また、本発明は、上記カプセル皮膜を用いて得られるカプセルにより上記課題を解決したものである。
また、本発明は、内容物をゼラチン及び杜仲加工物を含有するカプセル皮膜で成形したカプセルに充填するか、又は該カプセル皮膜で被包成形することを特徴とするカプセルの製造方法により上記課題を解決したものである。
That is, this invention solves the said subject with the capsule membrane | film | coat characterized by containing gelatin and a processed product.
Moreover, this invention solves the said subject with the capsule obtained using the said capsule membrane | film | coat.
Further, the present invention provides the above-mentioned problem by a capsule manufacturing method, wherein the contents are filled in a capsule formed with a capsule film containing gelatin and a processed product, or encapsulated with the capsule film. It has been solved.

本発明によれば、ゼラチン独特の獣臭、すなわちゼラチン臭が低減され、遮光性に優れたカプセル皮膜及びこれを用いたカプセルを提供できる。本発明により得られるカプセルは、添加物表示が不要なため、添加物を含まない製品を望む消費者の要望に沿うものである。   ADVANTAGE OF THE INVENTION According to this invention, the capsule membrane | film | coat using the capsule membrane | film | coat with which the animal odor peculiar to gelatin, ie, gelatin odor, was reduced, and was excellent in light-shielding property can be provided. Since the capsule obtained by the present invention does not require an additive label, it meets the needs of consumers who desire a product that does not contain an additive.

本発明に用いられるゼラチンは、例えば、牛、豚、鶏、魚等の皮、骨、腱等を原料とし、酸又はアルカリで処理して得られる粗コラーゲンを加熱抽出して製造されたものが用いられる。また、ゼラチンの加水分解物や酸素分解物、アシル化ゼラチン等のゼラチン誘導体等を用いることもできる。
ゼラチンのゼリー強度は、100〜300gが好ましく、特に120〜270gが好ましい。ゼリー強度は、JIS K−6503(2001)に準拠して測定できる。
The gelatin used in the present invention is produced, for example, by heating and extracting crude collagen obtained by treating with skin, bone, tendon, etc. of cattle, pigs, chickens, fish, etc., and treating with acid or alkali. Used. Further, gelatin hydrolyzate, oxygen decomposed product, gelatin derivatives such as acylated gelatin, and the like can also be used.
The jelly strength of gelatin is preferably from 100 to 300 g, particularly preferably from 120 to 270 g. The jelly strength can be measured according to JIS K-6503 (2001).

カプセル皮膜におけるゼラチンの含有量は、カプセルの機械的強度や成形時の皮膜の均一性等を考慮して適宜検討すればよいが、乾燥質量で、50〜85質量%が好ましく、特に65〜80質量%が好ましい。   The gelatin content in the capsule film may be appropriately examined in consideration of the mechanical strength of the capsule, the uniformity of the film at the time of molding, etc., but is preferably 50 to 85% by mass, particularly 65 to 80% by dry mass. Mass% is preferred.

本発明に用いられる杜仲加工物は、杜仲(Eucommia ulmoides oliver)の粉砕物(粗粉末、細粉末のいずれも含む)、杜仲を溶剤で抽出して得られる抽出物、その希釈液、濃縮液、乾燥末、顆粒又はペースト等が包含される。杜仲加工物は、市販品を使用してもよく、また、杜仲抽出物は、杜仲を後掲の抽出工程により取得してもよい。   The processed product used in the present invention is a crushed product of Eucommia ulmoides oliver (including both coarse powder and fine powder), an extract obtained by extracting the solvent with a solvent, a diluted solution thereof, a concentrated solution, Dry powder, granules or pastes are included. A commercially available product may be used as the Tochu processed product, and the Tochu extract may be obtained through the extraction process described later.

杜仲の使用部位は特に限定されず、適宜選択することが可能であるが、例えば、葉、樹皮、果実、種子、葉柄、木部、根、根茎等が例示される。これらは1種又は2種以上を組み合わせて使用することができる。なかでも、ゼラチン臭を低減する点及び遮光性を付与する点から、葉を用いるのが好ましい。
抽出する際には、これらをそのまま使用しても、粉砕、切断、乾燥等の前処理を行ってもよい。
The use site of Tochu is not particularly limited and can be appropriately selected. Examples thereof include leaves, bark, fruits, seeds, petiole, xylem, roots, rhizomes and the like. These can be used alone or in combination of two or more. Among these, it is preferable to use leaves from the viewpoint of reducing gelatin odor and imparting light shielding properties.
When extracting, these may be used as they are or may be subjected to pretreatment such as pulverization, cutting and drying.

抽出方法は、浸漬、煎出、浸出、還流抽出、超臨界抽出、超音波抽出、マイクロ波抽出等のいずれでもよい。
抽出溶剤としては、極性溶剤、非極性溶剤のいずれをも使用することができ、これらを混合して用いることもできる。例えば、水;メタノール、エタノール、プロパノール、ブタノール等のアルコール類;エチレングリコール、プロピレングリコール、ブチレングリコール等の多価アルコール類;アセトン、メチルエチルケトン等のケトン類;酢酸メチル、酢酸エチル等のエステル類;テトラヒドロフラン、ジエチルエーテル等の鎖状及び環状エーテル類;ポリエチレングリコール等のポリエーテル類;ジクロロメタン、クロロホルム、四塩化炭素等のハロゲン化炭化水素類;ヘキサン、シクロヘキサン、石油エーテル等の炭化水素類;ベンゼン、トルエン等の芳香族炭化水素類;ピリジン類;超臨界二酸化炭素;油脂、ワックス、その他菜種油、オリーブ油、大豆油などのオイルなどが挙げられ、これらは単独で又は2種以上を組み合わせて使用でき、溶剤を変えて繰り返し行うことも可能である。なかでも、水、アルコール類を用いるのが好ましい。水としては、例えば、水道水、精製水、蒸留水、イオン交換水が例示される。
The extraction method may be any of immersion, decoction, leaching, reflux extraction, supercritical extraction, ultrasonic extraction, microwave extraction, and the like.
As the extraction solvent, either a polar solvent or a nonpolar solvent can be used, and these can also be mixed and used. For example, water; alcohols such as methanol, ethanol, propanol and butanol; polyhydric alcohols such as ethylene glycol, propylene glycol and butylene glycol; ketones such as acetone and methyl ethyl ketone; esters such as methyl acetate and ethyl acetate; tetrahydrofuran Linear and cyclic ethers such as diethyl ether; polyethers such as polyethylene glycol; halogenated hydrocarbons such as dichloromethane, chloroform and carbon tetrachloride; hydrocarbons such as hexane, cyclohexane and petroleum ether; benzene and toluene Aromatic hydrocarbons such as; pyridines; supercritical carbon dioxide; oils, waxes, oils such as rapeseed oil, olive oil, soybean oil, etc., and these can be used alone or in combination of two or more. It is also possible to carry out repeatedly changed. Of these, water and alcohols are preferably used. Examples of water include tap water, purified water, distilled water, and ion exchange water.

抽出は、例えば杜仲葉1質量部に対して1〜50質量部の溶剤を用い、室温(25℃)〜100℃で5分〜数時間、好ましくは30〜60分浸漬又は加熱還流するのが好ましい。   For extraction, for example, 1 to 50 parts by mass of a solvent is used per 1 part by mass of Tochu Nakaba, and it is immersed or heated to reflux at room temperature (25 ° C.) to 100 ° C. for 5 minutes to several hours, preferably 30 to 60 minutes. preferable.

本発明に用いられる杜仲抽出物は、食品上・医薬品上許容し得る規格に適合し本発明の効果を発揮するものであれば粗精製物であってもよく、さらに得られた粗精製物を公知の分離精製方法を適宜組み合わせてこれらの純度を高めてもよい。精製手段としては、有機溶剤沈殿、遠心分離、限界濾過膜、高速液体クロマトグラフやカラムクロマトグラフ等が挙げられる。   The Tochu extract used in the present invention may be a crude product as long as it conforms to food and pharmaceutical acceptable standards and exhibits the effects of the present invention. These purities may be increased by appropriately combining known separation and purification methods. Examples of the purification means include organic solvent precipitation, centrifugation, ultrafiltration membrane, high performance liquid chromatograph, column chromatograph and the like.

杜仲抽出物には、ゲニポシド酸が含まれていることが好ましく、本発明において杜仲抽出物中のゲニポシド酸濃度は、6〜100mg/g、特に20〜80mg/gであるのが好ましい。なお、ゲニポシド酸濃度は、例えば後記実施例に記載の高速液体クロマトグラフ法にて測定できる。   It is preferable that geniposide acid is contained in the Tochu extract, and in the present invention, the geniposide acid concentration in the Tochu extract is preferably 6 to 100 mg / g, particularly preferably 20 to 80 mg / g. The geniposide acid concentration can be measured, for example, by the high performance liquid chromatograph method described in the examples below.

カプセル皮膜における杜仲加工物の含有量は、ゼラチン臭を低減する点及び遮光性を付与する点から、乾燥質量でゼラチン100質量部に対して1質量部以上が好ましく、更に5〜40質量部、特に8〜20質量部が好ましい。杜仲加工物の含有量が40質量部より多いと粘性が高くなり、皮膜中に泡が残存し易くなる。   The content of the processed product in the capsule film is preferably 1 part by mass or more with respect to 100 parts by mass of gelatin in terms of dry mass, from the viewpoint of reducing gelatin odor and imparting light shielding properties, and further 5 to 40 parts by mass, 8-20 mass parts is especially preferable. If the content of the processed product is more than 40 parts by mass, the viscosity becomes high and bubbles tend to remain in the film.

本発明のカプセル皮膜には、必要に応じて、カプセル皮膜に用いられる各種添加剤、例えば、ゼラチン以外の水溶性高分子、可塑剤、防腐剤、水分活性低下剤、pH調整剤等を配合することができる。
可塑剤としては、例えば、グリセリン、ソルビトール、プロピレングリコール、ポリエチレングリコール等が挙げられる。カプセル皮膜における可塑剤の含有量は、柔軟性の点から、ゼラチン100質量部に対して20〜50質量部が好ましく、特に30〜40質量部が好ましい。
In the capsule film of the present invention, various additives used for the capsule film, for example, water-soluble polymers other than gelatin, plasticizers, preservatives, water activity lowering agents, pH adjusters and the like are blended as necessary. be able to.
Examples of the plasticizer include glycerin, sorbitol, propylene glycol, polyethylene glycol and the like. The content of the plasticizer in the capsule film is preferably 20 to 50 parts by mass, particularly preferably 30 to 40 parts by mass with respect to 100 parts by mass of gelatin from the viewpoint of flexibility.

カプセル皮膜は、常法に従って製造することができる。例えば、ゼラチン、杜仲加工物、さらに必要に応じて各種添加剤を水に攪拌・分散させて、55〜98℃で攪拌・溶解させた後、真空脱泡すればよい。この時、杜仲加工物は、予め水に溶解後、濾過してから用いるのが好ましい。濾過手段としては、吸引濾過、減圧濾過、加圧濾過、遠心濾過、自然濾過のいずれでも良い。また、フィルターのかわりにふるいを使用し、前記濾過手段に準ずる篩過手段を採用することもできる。   The capsule film can be produced according to a conventional method. For example, gelatin, a processed product, and further, if necessary, various additives may be stirred and dispersed in water, stirred and dissolved at 55 to 98 ° C., and then vacuum degassed. At this time, it is preferable to use the Tochu processed product after it is dissolved in water and filtered. As a filtration means, any of suction filtration, vacuum filtration, pressure filtration, centrifugal filtration, and natural filtration may be used. Further, a sieving means similar to the filtering means may be employed instead of a filter.

カプセル皮膜を所定形状に成形、乾燥することでカプセルが得られる。カプセルとしては、ソフトカプセル、ハードカプセルが挙げられ、なかでも、皮膜厚さの調整可能範囲が広いことなどから、ソフトカプセルが好ましい。   A capsule can be obtained by forming the capsule film into a predetermined shape and drying it. Examples of the capsule include a soft capsule and a hard capsule, and among them, the soft capsule is preferable because the range in which the film thickness can be adjusted is wide.

カプセルの形状は、特に限定されず、例えば、オーバール(フットボール)型、オブロング(長楕円)型、ラウンド(球状)型等が挙げられる。   The shape of the capsule is not particularly limited, and examples thereof include an oval (football) type, an oblong (long ellipse) type, and a round (spherical) type.

カプセル皮膜の成形と内容物の充填のタイミングは、カプセルの種類によって異なるが、例えば、内容物を成形したカプセルに充填するか、又はカプセル皮膜で被包成形すればよい。
例えばソフトカプセルにするには、従来用いられているソフトカプセルの製法、例えばロータリー式全自動ソフトカプセル充填機等を用いた打ち抜き法、平板法、滴下法等を用いることができる。
The timing of forming the capsule film and filling the contents varies depending on the type of capsule, but for example, the capsule may be filled with the contents or encapsulated with the capsule film.
For example, soft capsules can be produced by a conventionally used method for producing soft capsules, such as a punching method using a rotary fully automatic soft capsule filling machine, a flat plate method, a dropping method, or the like.

本発明のカプセルは、医薬品、医薬部外品、食品、化粧品等種々の用途に利用することができ、カプセル内容物の組成は用途に応じて適宜決定される。内容物の形態は溶液状、懸濁液状、ペースト状、粉末状、顆粒状等いずれであってもよい。   The capsule of the present invention can be used for various uses such as pharmaceuticals, quasi drugs, foods, and cosmetics, and the composition of the capsule contents is appropriately determined according to the use. The content may be in the form of a solution, a suspension, a paste, a powder, a granule or the like.

以下、本発明について実施例をあげて具体的に説明するが、本発明はこれらによって何等限定されるものではない。   Hereinafter, the present invention will be specifically described with reference to examples, but the present invention is not limited to these examples.

<原料>
原料は下記のものを使用した。
ゼラチン:(株)ニッピ製、豚皮由来酸処理ゼラチン
グリセリン:阪本薬品工業(株)製、食品添加物グレード
杜仲葉エキス:小林製薬(株)製、粉末原料、ゲニポシド酸濃度60mg/g以上
カラメル色素:仙波糖化工業(株)製、食品添加物グレード「BD−2」
<Raw material>
The following materials were used.
Gelatin: manufactured by Nippi Co., Ltd., pig skin-derived acid-treated gelatin Glycerin: manufactured by Sakamoto Pharmaceutical Co., Ltd., food additive grade Tochu Nakaba extract: manufactured by Kobayashi Pharmaceutical Co., Ltd., powder raw material, geniposide acid concentration of 60 mg / g or more Caramel Dye: Food additive grade “BD-2” manufactured by Senba Saccharification Co., Ltd.

<ゲニポシド酸濃度の測定>
試料を濾過後、適宜希釈し、高速液体クロマトグラフを用い、オクタデシル基導入液体クロマトグラフ用パックドカラム(YMC−Pack ODS−A、φ6mm×15cm:(株)ワイエムシイ製)を装着し、カラム温度 室温、流量1.0ml/minで測定した。移動相は水、メタノール及びリン酸の混液とし、UV検出器波長は245nmの条件で行った。
<Measurement of geniposide acid concentration>
The sample is filtered, diluted as appropriate, and a high-performance liquid chromatograph is used, and a packed column (YMC-Pack ODS-A, φ6 mm × 15 cm, manufactured by YMC Co., Ltd.) for octadecyl group-introduced liquid chromatograph is attached. , And measured at a flow rate of 1.0 ml / min. The mobile phase was a mixture of water, methanol and phosphoric acid, and the UV detector wavelength was 245 nm.

実施例1
(1)調製方法
杜仲葉エキスを水に溶解後、75μmふるいで自然篩過して溶液残渣を除去した。表1に示した量のゼラチン、グリセリン、杜仲葉エキス(乾燥質量換算)、カラメル色素をそれぞれ水に攪拌・分散させた後、60〜70℃で攪拌しながら溶解させ、真空脱泡して試料1−13を得た。各試料を、薄層クロマトグラフ用アプリケータを用いて、約1mmの厚さになるように均一に押し広げて、24時間乾燥した後フィルム状のソフトカプセル皮膜を得た。
Example 1
(1) Preparation method After the Tochu Nakaba extract was dissolved in water, the solution residue was removed by natural sieving with a 75 μm sieve. After stirring and dispersing gelatin, glycerin, chunakaba extract (calculated in terms of dry mass) and caramel pigment in water in the amounts shown in Table 1, each sample was dissolved with stirring at 60 to 70 ° C., vacuum degassed, and sample 1-13 was obtained. Each sample was uniformly spread to a thickness of about 1 mm using a thin-layer chromatograph applicator and dried for 24 hours to obtain a film-like soft capsule film.

(2)遮光性の測定
上記(1)で得られたソフトカプセル皮膜の遮光性を、「波長555nmにおけるフィルム厚さ1mmの場合の空気に対する吸光度」を指標として測定した。
各フィルムの厚さ(D)〔mm〕を測定後、「日本分光社製 分光光度計 V-530」を用いて空気をブランクとして吸光度(A)を測定した。吸光度は光路長に比例することから(第8版食品添加物公定書解説書(廣川書店)、B-83頁<16.紫外可視吸光度測定法>)、吸光度の値(A)を光路長(=フィルム厚さ(D))で割ってフィルム厚さの誤差を補正した。
その結果を表1に示す。
(2) Measurement of light-shielding property The light-shielding property of the soft capsule film obtained in the above (1) was measured using “absorbance with respect to air when the film thickness is 1 mm at a wavelength of 555 nm” as an index.
After measuring the thickness (D) [mm] of each film, the absorbance (A) was measured using “Spectrophotometer V-530 manufactured by JASCO Corporation” with air as a blank. Since the absorbance is proportional to the optical path length (8th edition Food Additives Official Manual (Yodogawa Shoten), page B-83 <16. UV-Vis Absorbance Measurement Method>), the absorbance value (A) is calculated from the optical path length (A). = Film thickness (D)) to correct for film thickness error.
The results are shown in Table 1.

Figure 0005588134
Figure 0005588134

上記表1から明らかなように、杜仲葉エキスを配合することで遮光性を付与できることが判る。杜仲葉エキスの配合量を増やすに従って遮光性が向上し、特に、杜仲葉エキスの配合量をゼラチン100質量部に対し、5質量部以上とすることで、可視光の透過度は概ね1割程度となり、優れた遮光性が得られる。一方、杜仲葉エキスの配合量が多くなると粘性が高くなり、皮膜中に泡が残存し易くなる傾向が見られたため、杜仲葉エキスの配合量としては40質量部以下、特に5〜40質量部が好ましかった。   As is apparent from Table 1 above, it can be seen that light-shielding properties can be imparted by blending the nakanaka leaf extract. The light shielding property improves as the blending amount of the chunaka leaf extract increases. In particular, the transmittance of visible light is about 10% when the blending amount of the chunaka leaf extract is 5 parts by mass or more with respect to 100 parts by mass of gelatin. Thus, excellent light shielding properties can be obtained. On the other hand, when the blending amount of the chunaka leaf extract is increased, the viscosity becomes high and bubbles tend to remain in the film. Therefore, the blending amount of the chunaka leaf extract is 40 parts by mass or less, particularly 5 to 40 parts by mass. Was preferred.

実施例2
(1)調製方法
実施例1と同様にして、表2に示した量のゼラチン、グリセリン、杜仲葉エキス(乾燥質量換算)、カラメル色素をそれぞれ水に攪拌・分散させた後、70℃で攪拌しながら溶解させ、真空脱泡してカプセル皮膜を得た。これらのカプセル皮膜を用いて、ロータリー式全自動ソフトカプセル充填機を使用し、植物油含有ソフトカプセル(試験例1−13)を製造した。
Example 2
(1) Preparation Method In the same manner as in Example 1, the amounts of gelatin, glycerin, chunaka leaf extract (in terms of dry mass), and caramel color shown in Table 2 were each stirred and dispersed in water, followed by stirring at 70 ° C. Then, it was dissolved and vacuum degassed to obtain a capsule film. Using these capsule films, a rotary type fully automatic soft capsule filling machine was used to produce a vegetable oil-containing soft capsule (Test Example 1-13).

(2)ゼラチン臭の評価
専門パネル6名により、各ソフトカプセルの「ゼラチン臭」を下記評価基準に従って評価し、平均を求めた。結果を表2に示す。なお、「ゼラチン臭」とは、「ゼラチン独特の獣臭」をいう。
〔ゼラチン臭の評価基準〕
3:ゼラチン臭を強く感じる
2:ゼラチン臭を感じる
1:ゼラチン臭をやや感じる
0:ゼラチン臭を感じない
(2) Evaluation of gelatin odor 6 expert panels evaluated the “gelatin odor” of each soft capsule in accordance with the following evaluation criteria, and determined the average. The results are shown in Table 2. The “gelatin odor” means “a gelatinous animal odor”.
[Evaluation criteria for gelatin odor]
3: Strongly feel the gelatin odor 2: Feel the gelatin odor 1: Feel a little gelatin odor 0: Do not feel the gelatin odor

Figure 0005588134
Figure 0005588134

表2より明らかなように、杜仲葉エキスを配合することでゼラチン臭が低減されることが判る。杜仲葉エキスの配合量を増やすに従って低減効果が発揮され、特に、杜仲葉エキスをゼラチン100質量部に対して1質量部以上、特に5質量部以上とすることで、十分な低減効果が得られた。   As is apparent from Table 2, it can be seen that the gelatin odor is reduced by blending the nakanaka leaf extract. The reduction effect is exhibited as the blending amount of the chunaka leaf extract is increased. In particular, when the chunaka leaf extract is 1 part by mass or more, particularly 5 parts by mass or more with respect to 100 parts by mass of gelatin, a sufficient reduction effect is obtained. It was.

Claims (6)

ゼラチン及び杜仲葉を溶剤で抽出して得られるゲニポシド酸を6〜100mg/g含む杜仲葉の溶剤抽出物を乾燥質量換算でゼラチン100質量部に対して1〜40質量部含有することを特徴とするカプセル皮膜。 Wherein gelatin, and in that it contains 1 to 40 parts by weight per 100 parts by weight of gelatin to geniposidic acid obtained by extraction with a solvent and the solvent extract of Eucommia leaf comprising 6~100mg / g on a dry weight in terms of Eucommia leaf Capsule film. 前記杜仲葉の溶剤抽出物が、杜仲葉の水及び/又はエタノールの抽出物である請求項1記載のカプセル皮膜。 The capsule film according to claim 1, wherein the solvent extract of Tochu Nakaba is an extract of Tochu Nakaba water and / or ethanol . 前記杜仲葉の溶剤抽出物が杜仲葉の溶剤抽出物の乾燥末である請求項1又は2記載のカプセル皮膜。   The capsule film according to claim 1 or 2, wherein the solvent extract of Tochu Nakaba is a dry powder of the solvent extract of Tochu Nakaba. カプセルがソフトカプセルである請求項1〜のいずれか1項記載のカプセル皮膜。 The capsule film according to any one of claims 1 to 3 , wherein the capsule is a soft capsule. 請求項1〜のいずれか1項記載のカプセル皮膜を用いて得られるカプセル。 The capsule obtained using the capsule membrane | film | coat of any one of Claims 1-4 . 内容物をゼラチン及び杜仲葉を溶剤で抽出して得られるゲニポシド酸を6〜100mg/g含む杜仲葉の溶剤抽出物を乾燥質量換算でゼラチン100質量部に対して1〜40質量部含有するカプセル皮膜で成形したカプセルに充填するか、又は該カプセル皮膜で被包成形することを特徴とするカプセルの製造方法。 The contents were, gelatin, and 1 to 40 parts by weight containing based on 100 parts by weight of gelatin geniposidic acid obtained by extraction with a solvent and the solvent extract of Eucommia leaf comprising 6~100mg / g on a dry weight in terms of Eucommia leaf A method for producing a capsule, comprising filling a capsule formed with a capsule film, or encapsulating with a capsule film.
JP2009184264A 2009-08-07 2009-08-07 Capsule film Active JP5588134B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009184264A JP5588134B2 (en) 2009-08-07 2009-08-07 Capsule film

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009184264A JP5588134B2 (en) 2009-08-07 2009-08-07 Capsule film

Publications (2)

Publication Number Publication Date
JP2011037731A JP2011037731A (en) 2011-02-24
JP5588134B2 true JP5588134B2 (en) 2014-09-10

Family

ID=43765917

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009184264A Active JP5588134B2 (en) 2009-08-07 2009-08-07 Capsule film

Country Status (1)

Country Link
JP (1) JP5588134B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120070475A1 (en) * 2010-03-11 2012-03-22 Pepsico, Inc Zero Calorie Polyphenol Aqueous Dispersions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6059205B2 (en) * 1981-12-24 1985-12-24 帝三製薬株式会社 Method for manufacturing soft capsules for encapsulating photolabile drugs
JPS6423860A (en) * 1987-07-17 1989-01-26 Suntory Ltd Soft capsule
JPH0312231A (en) * 1989-06-09 1991-01-21 Kotobuki Akad:Kk Capsule film composition
JP2004357584A (en) * 2003-06-04 2004-12-24 Minato Pharmaceutical Co Ltd Composition with masked unpleasant odor
JP4666944B2 (en) * 2004-03-31 2011-04-06 小林製薬株式会社 Deodorant containing Tochu
JP5088846B2 (en) * 2006-03-03 2012-12-05 小林製薬株式会社 A fraction of Tochu Nakaha extract and an anti-obesity agent containing the fraction

Also Published As

Publication number Publication date
JP2011037731A (en) 2011-02-24

Similar Documents

Publication Publication Date Title
CN103702675B (en) With lacquer tree extract of active flavonoids for increasing content and preparation method thereof
Osuagwu et al. The phytochemical composition and antimicrobial activity of Dialium guineense, Vitex doniana and Dennettia tripetala leaves
CN103230473A (en) Lycium ruthenicum Murr effective extract and its extraction method and use
US10610562B2 (en) Instant water soluble bioactive dietary phytonutrients composition of spice/herb extracts and a process for its preparation
Kowalska et al. Evaluation of glycerol usage for the extraction of anthocyanins from black chokeberry and elderberry fruits
US20100040758A1 (en) Integrated production of phytochemical rich plant products or isolates from green vegetation
Dewi et al. Investigating the role of solvent type and microwave selective heating on the extraction of phenolic compounds from cacao (Theobroma cacao L.) pod husk
Živković et al. Extraction and analysis of condensed tannins in Castanea sativa Mill.
JP2012121869A (en) Bitter taste inhibitor
KR20110099950A (en) Natural colors from marine algae and method for preparing the same
CN111825647B (en) Method for extracting anthocyanin from aronia melanocarpa
JP5588134B2 (en) Capsule film
Mann et al. Value addition scenario of arid foods of desert area and evaluation of their nutritional and phytochemical potential
KR20200145897A (en) Method for producing extracts of sweet potato with enhanced antioxidative activity and extracts of sweet potato produced by the same method
Yağmur et al. Microencapsulation of ellagic acid extracted from pomegranate peel onto Spirulina: Characterization, loading, and storage stability properties
KR102109780B1 (en) Method for producing the extracts of natural material using ethyl lactate
CN105146513B (en) A kind of preparation method of the health care particle containing rose
JP2015070820A (en) Water-soluble preparation of resveratrols, and manufacturing method of the same
KR101457956B1 (en) Extraction of natural pigment using sorghum by-product and there of composition
Retnaningtyas et al. Study of Antioxidant Activity Combination of Arabica Coffee Leaf Ethanol Extract and Roselle Flower Petal Water Extract
CN1747962A (en) Compound, process for producing the same and use thereof
Gunathilake et al. Optimizing the extraction of bioactive compounds from leaves of Gymnema lactiferum, an edible green leafy vegetable
CN106974946A (en) The method that general flavone is extracted from sunflower seeds
Kumar Dry Milling Characteristics and Polyphenolic Contents of Adapted Colored Corn Varieties and Polyphenol Extraction by Combining Deep Eutectic Solvents and Ultrasound
Lõugas Study on physico-chemical properties and some bioactive compounds of sea buckthorn (Hippophae rhamnoides L.)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120515

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130910

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130913

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140212

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140507

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20140626

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140722

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140725

R150 Certificate of patent or registration of utility model

Ref document number: 5588134

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250